Loading...
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a rare lung disease characterised by progressive loss of lung function, dyspnoea and cough. IPF has a variable clinical course but a poor prognosis. Nintedanib, a tyrosine kinase inhibitor, is one of two drugs approved for the treatment of IPF. In clinical tria...
Na minha lista:
| Udgivet i: | BMJ Open Respir Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5531305/ https://ncbi.nlm.nih.gov/pubmed/28883926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2017-000192 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|